Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14

1.

Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.

Minasian LM, Tangen CM, Wickerham DL.

Semin Oncol. 2015 Oct;42(5):748-63. doi: 10.1053/j.seminoncol.2015.07.006. Epub 2015 Jul 10. Review.

PMID:
26433556
2.

Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Sutcliffe S, Till C, Jenkins FJ, Gaydos CA, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Nelson WG, De Marzo AM, Platz EA.

Cancer Causes Control. 2015 Jan;26(1):35-44. doi: 10.1007/s10552-014-0480-5. Epub 2014 Oct 31.

3.

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S, Szczepanek C, Ryan A, Carlin S, Hill S, Goodman PJ, Padberg RM, Minasian LM, Meyskens FL, Thompson IM Jr.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1638-48. doi: 10.1158/1055-9965.EPI-14-0202. Epub 2014 Jul 15.

4.

Statin drug use is not associated with prostate cancer risk in men who are regularly screened.

Platz EA, Tangen CM, Goodman PJ, Till C, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Lucia MS, Thompson IM Jr, Kristal AR.

J Urol. 2014 Aug;192(2):379-84. doi: 10.1016/j.juro.2014.01.095. Epub 2014 Feb 8.

5.

A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.

Bosland MC.

Cancer Lett. 2013 Jun 28;334(1):28-33. doi: 10.1016/j.canlet.2012.08.027. Epub 2012 Aug 29. Review.

6.

Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Sutcliffe S, Till C, Gaydos CA, Jenkins FJ, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Zenilman JM, Nelson WG, De Marzo AM, Platz EA.

Cancer Causes Control. 2012 Sep;23(9):1511-8. doi: 10.1007/s10552-012-0028-5. Epub 2012 Jul 19.

7.

Hormones and prostate carcinogenesis: Androgens and estrogens.

Bosland MC, Mahmoud AM.

J Carcinog. 2011;10:33. doi: 10.4103/1477-3163.90678. Epub 2011 Dec 8.

8.

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence.

Ozten-KandaƟ N, Bosland MC.

J Carcinog. 2011;10:27. doi: 10.4103/1477-3163.90438. Epub 2011 Nov 30.

9.

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Vickers AJ, Till C, Tangen CM, Lilja H, Thompson IM.

J Natl Cancer Inst. 2011 Mar 16;103(6):462-9. doi: 10.1093/jnci/djr028. Epub 2011 Feb 24.

10.

Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Shepherd BE, Redman MW, Ankerst DP.

J Am Stat Assoc. 2008 Dec 1;103(484):1392-1404.

11.

Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Sutcliffe S, Viscidi RP, Till C, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Zenilman JM, De Marzo AM, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):614-8. doi: 10.1158/1055-9965.EPI-09-1080.

12.

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Thompson IM Jr, Kristal AR.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2807-13. doi: 10.1158/1055-9965.EPI-09-0472. Epub 2009 Nov 3.

13.

Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.

Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman CA Jr, Thompson IM.

Cancer Prev Res (Phila). 2008 Aug;1(3):174-81. doi: 10.1158/1940-6207.CAPR-08-0092. Epub 2008 May 18.

14.

Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.

Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, De Marzo AM, Platz EA.

Int J Cancer. 2009 May 1;124(9):2082-7. doi: 10.1002/ijc.24144.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk